Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - OTHER LONG-TERM ASSETS
Other Long-term Assets YMAB - Y-mAbs Therapeutics, Inc.
18.3 M
LAST VALUE
79.30%
2 YEAR CAGR
118.10%
5 YEAR CAGR
0.00%
10 YEAR CAGR